Results 131 to 140 of about 1,405,405 (194)

Macrophage activation syndrome in a 13-month-old child with systemic juvenile idiopathic arthritis mimicking sepsis: a diagnostic challenge and case report. [PDF]

Ann Med Surg (Lond)
Subedi P, Rai S, Aryal R, Nepal AR, Khatiwada P.   +4 more
europepmc   +1 more source

Diagnostic challenges of systemic juvenile idiopathic arthritis with aberrant M-protein expression: a case report. [PDF]

BMC Pediatr
Liang S, Yu W, Zhong P, Tao C, Jia C, Zhang L.   +5 more
europepmc   +1 more source

Distinct cytokine and chemokine alterations in bronchoalveolar fluid from patients with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD). [PDF]

Arthritis Res Ther
Romankevych I, Sproles A, Do T, Auld L, Sabit T, Chhaing R, Baker E, Kumar A, Trapnell B, Carey B, Brewington JJ, Towe C, Grom A, Schulert G.   +13 more
europepmc   +1 more source

Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis. [PDF]

Eur J Pediatr
Sarısoy D, Aydın F, Taş Ö, Bahçeci O, Öksüz Aydın B, Erorhan E, Akkaya Hocagil T, Özçakar ZB.   +7 more
europepmc   +1 more source

Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy. [PDF]

Front Immunol
Freeman WJ, Rife EC, Cron RQ.
europepmc   +1 more source

First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab. [PDF]

Kidney Med
Jacobs L, Badot V, Nagant C, Ghorra N, Corazza F, Bienfait L, Nortier J, Taghavi M.   +7 more
europepmc   +1 more source

Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. [PDF]

ACR Open Rheumatol
Rife E, Zhai G, Altaye M, Andringa J, Brunner HI, Canna S, Henderson LA, Kimura Y, Lieberman SM, Riskalla M, Towe C, Vogel T, Wobma H, Schulert G, PGALD Validation Consortium Investigators.   +14 more
europepmc   +1 more source

Case Report: Ruxolitinib for systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome: two pediatric cases and literature review. [PDF]

Front Pediatr
Liu H, Wang Z, Zhang W.
europepmc   +1 more source

Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study. [PDF]

Rheumatol Ther
Li C, Zhang J, Yu H, Lu M, Yang S, Liu C, Zeng P, Zhao B, Li X, Zheng W, Du Y, Zhang W, Li Z, Hu X, Lai J, Xu Q, Zhang X, Wang X, Adili P, Qu W.   +19 more
europepmc   +1 more source

tRF-30-FP18LPMBQ4NK in Systemic Juvenile Idiopathic Arthritis: A Promising Diagnostic and Disease Activity Biomarker. [PDF]

Ann N Y Acad Sci
Huang J, Pan Y, Jin J, Shao X, Zheng W, Fan Z, Yu H.   +6 more
europepmc   +1 more source